TPD52 and prostate carcinoma: To examine the effect of PC-1/PrLZ on prostate cancer cell radiosensitivity, we knocked down endogenous PC-1/PrLZ with shRNA in C4-2 cells expressing high levels of PC-1/PrLZ.